These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27751785)

  • 21. Ca 125 as a marker of tumor activity in advanced urothelial malignancy.
    Izes JK; Dyer MW; Callum MG; Bankes P; Libertino JA; Caffrey JA
    J Urol; 2001 Jun; 165(6 Pt 1):1908-13. PubMed ID: 11371879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
    Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T
    BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging blood-based biomarkers for detection of gastric cancer.
    Kalniņa Z; Meistere I; Kikuste I; Tolmanis I; Zayakin P; Linē A
    World J Gastroenterol; 2015 Nov; 21(41):11636-53. PubMed ID: 26556992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
    Beeharry MK; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.
    Ali SM; Miller VA; Ross JS; Pal SK
    Eur Urol; 2015 Jun; 67(6):1195-1196. PubMed ID: 25630452
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Yörüker EE; Holdenrieder S; Gezer U
    Clin Chim Acta; 2016 Apr; 455():26-32. PubMed ID: 26797671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.
    Ikeda S; Hansel DE; Kurzrock R
    Cancer Treat Rev; 2015 Sep; 41(8):699-706. PubMed ID: 26138514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From new genetic and histological classifications to direct treatment].
    Compérat E; Furudoï A; Varinot J; Rioux-Leclerq N
    Ann Pathol; 2016 Aug; 36(4):275-8. PubMed ID: 27474530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection.
    Tao J; Yang X; Li P; Wei J; Deng X; Cheng Y; Qin C; Ju X; Meng X; Li J; Gu M; Lu Q; Yin C
    Mol Med Rep; 2015 Nov; 12(5):6752-60. PubMed ID: 26323574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
    Anker P; Mulcahy H; Stroun M
    Int J Cancer; 2003 Jan; 103(2):149-52. PubMed ID: 12455027
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.
    Galsky MD; Seng S; Camacho LH; Chiorean EG; Mulkerin D; Hong DS; Oh WK; Bajorin DF
    Clin Genitourin Cancer; 2011 Sep; 9(1):27-30. PubMed ID: 21700509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
    Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 35. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
    Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
    Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumors.
    Kruck S; Gakis G; Stenzl A
    Anticancer Res; 2011 Jun; 31(6):2053-7. PubMed ID: 21737622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translating metastasis-related biomarkers to the clinic--progress and pitfalls.
    Bidard FC; Pierga JY; Soria JC; Thiery JP
    Nat Rev Clin Oncol; 2013 Mar; 10(3):169-79. PubMed ID: 23381003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical impact of peripheral lymphocyte counts for metastatic urothelial carcinoma patients treated with chemotherapy].
    Sekita N; Nishikawa R; Fujimura M; Takeuchi N; Ogino H; Shibata N; Omura S; Mikami K
    Hinyokika Kiyo; 2014 May; 60(5):215-9. PubMed ID: 24894856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.